AtriCure, Inc. ATRC recently announced the treatment of the first patient with the AtriClip FLEX-Mini device. The device recently received the FDA 510(k) clearance. The AtriClip FLEX-Mini, the ...
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), today announced that it has ...
Clinical evidence demonstrates that AtriClip® devices exclude and electrically isolate the left atrial appendage AtriClip devices are the most widely implanted left atrial appendage management devices ...
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (ATRC) (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, ...
Shares of West Chester, OH-based AtriCure soared on news that the FDA approved the company's AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System, a device which blocks blood clots during ...
You have full access to this article via your institution. In the referenced study from our centre (which also states the potential limitations of the study) 3, we have further validated the long-term ...